Showing results (271-280 of 322) with videos related to

Sort By:
Pageof 33
Journal of the American Heart Association|April 16, 2026
Alternative Rule-Out Cutoffs for a Novel High-Sensitivity Cardiac Troponin I Assay in Patients With Suspected Myocardial InfarctionKoray Durak, Pedro Lopez-Ayala, Luca Koechlin, et al.
American Heart Journal|December 2, 2023
External validation of the 0/1h-algorithm and derivation of a 0/2h-algorithm using a new point-of-care Hs-cTnI assayLuca Koechlin, Jasper Boeddinghaus, Pedro Lopez-Ayala, et al.
Journal of Clinical Medicine|April 3, 2021
External Validation and Extension of a Clinical Score for the Discrimination of Type 2 Myocardial InfarctionThomas Nestelberger, Pedro Lopez-Ayala, Jasper Boeddinghaus, et al.
Circulation|February 12, 2024
Machine Learning for Myocardial Infarction Compared With Guideline-Recommended Diagnostic PathwaysJasper Boeddinghaus, Dimitrios Doudesis, Pedro Lopez-Ayala, et al.
IEEE Journal of Biomedical and Health Informatics|March 3, 2025
A Proposal for Automatic Evaluation of Human Functional Limitations in Activities of Daily LivingAlvaro Nieva-Suarez, Irene Guardiola-Luna, Alessandro Melino-Carrero, et al.
European Heart Journal|November 30, 2017
Indications and practical approach to non-invasive ventilation in acute heart failureJosep Masip, W Frank Peacock, Susanna Price, et al.
European Heart Journal. Acute Cardiovascular Care|July 12, 2023
Comparing the utility of clinical risk scores and integrated clinical judgement in patients with suspected acute coronary syndromeMario Meier, Jasper Boeddinghaus, Thomas Nestelberger, et al.
JACC. Advances|May 23, 2025
Derivation and Validation of ESC-0/1-h Algorithm for High-Sensitivity Troponin T and I in Cancer PatientsPaolo Bima, Pedro Lopez-Ayala, Luca Koechlin, et al.
Future Oncology (London, England)|June 14, 2025
Predictive risk factors of recurrence in breast cancer after neoadjuvant treatment: the NEORISK studyFranco Antonio, Luisa Carbognin, Ida Paris, et al.
Annals of Translational Medicine|January 20, 2023
Efficacy and safety of neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy regimen in Chinese patients with HER2-positive early breast cancer: a real-world retrospective multi-center cohort studyMeirong Zhou, Shouman Wang, Nengbin Wan, et al.
Pageof 33